Get the Stockscreener App
1.83
3.39%
0.06
After Hours:
1.83
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Forecast
The X T L Biopharmaceuticals Ltd Adr (XTLB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.5272, representing a -16.55% decrease from the current price of $1.83. The highest analyst price target is $1.6121, and the lowest is $1.4423.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XTLB Price Target
Average 1.7118
(-6.46% Downside)
Is X T L Biopharmaceuticals Ltd Adr (XTLB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.58 | Neutral |
| STOCH(9,6) | 31.49 | Neutral |
| STOCHRSI(14) | 25.55 | Neutral |
| MACD(12,26) | -0.0833 | Buy |
| ADX(14) | 17.58 | Neutral |
| William %R | -78.25 | Neutral |
| CCI(14) | -56.74 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.8115
Buy
|
1.8171
Buy
|
| MA20 |
1.8328
Sell
|
1.8677
Sell
|
| MA50 |
2.1152
Sell
|
2.0615
Sell
|
| MA100 |
2.3744
Sell
|
2.192
Sell
|
| MA200 |
2.2228
Sell
|
2.0039
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, XTLB could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on XTLB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.58 indicates that XTLB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 31.49 indicates that XTLB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.55 indicates that XTLB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.58 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -56.74 indicates that XTLB is still oversold but not to an extreme extent.
Long-term XTLB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about X T L Biopharmaceuticals Ltd Adr financial reports and earnings history, X T L Biopharmaceuticals Ltd Adr (XTLB) stock could reach $2.7706 by 2030, $2.0587 by 2040 and $3.4995 by 2050. See the projected annual prices until 2050 of the X T L Biopharmaceuticals Ltd Adr stock below:
- X T L Biopharmaceuticals Ltd Adr (XTLB) is expected to reach an average price of $1.4173 in 2035, with a high prediction of $1.6072 and a low estimate of $1.3926. This indicates an $-22.55% rise from the last recorded price of $1.83.
- X T L Biopharmaceuticals Ltd Adr (XTLB) stock is projected to chart a bullish course in 2040, with an average price target of $1.9493, representing an $6.52% surge from its current level. The forecast ranges from a conservative $1.8589 to a sky-high $2.0587.
- Our analysts predict X T L Biopharmaceuticals Ltd Adr (XTLB) to jump 24.97% by 2045, soaring from $2.1563 to an average price of $2.287, potentially reaching $2.4368. While $2.1563 is the low estimate, the potential upside is significant.
- X T L Biopharmaceuticals Ltd Adr (XTLB) stock is expected to climb by 2050, reaching an average of $2.9405, a $60.68% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.4995 and $2.6402, respectively, highlighting the market's uncertainty.
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Year by Year Forecast
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2024
Our forecast for XTLB stock price in 2024 now indicates an average price target of $2.8789 with a high forecast of $4.9897 and a low forecast of $0.7681. The average prediction reflects an increase of +57.32% from the last recorded price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $1.4855 | $1.4423 | $1.6121 | -18.83% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2025
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) is expected to reach an average price of $1.8871 in 2025, with a high prediction of $2.9259 and a low estimate of $0.8483. This indicates an +3.12% rise from the last recorded price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.5226 | $1.4226 | $1.8424 | -16.80% |
| February, 2025 | $1.5629 | $1.4827 | $2.0078 | -14.59% |
| March, 2025 | $1.0632 | $1.054 | $1.7731 | -41.90% |
| April, 2025 | $1.2836 | $0.8483 | $1.5436 | -29.86% |
| May, 2025 | $1.3538 | $1.2736 | $1.5838 | -26.02% |
| June, 2025 | $1.5641 | $1.344 | $1.6741 | -14.53% |
| July, 2025 | $1.8145 | $1.3942 | $2.3143 | -0.85% |
| August, 2025 | $1.6747 | $1.5946 | $1.8245 | -8.48% |
| September, 2025 | $1.975 | $1.6649 | $2.3246 | +7.92% |
| October, 2025 | $2.2954 | $1.8251 | $2.5753 | +25.43% |
| November, 2025 | $2.3756 | $1.9566 | $2.4946 | +29.82% |
| December, 2025 | $2.556 | $2.0957 | $2.9259 | +39.67% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2026
The predicted value for X T L Biopharmaceuticals Ltd Adr (XTLB) in 2026 is set at an average of $4.6924. Estimates vary from a peak of $6.9187 to a trough of $2.4661, indicating an +156.41% surge from the present price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6358 | $2.4661 | $2.7663 | +44.03% |
| February, 2026 | $3.2565 | $2.4963 | $3.6265 | +77.95% |
| March, 2026 | $3.3368 | $3.2466 | $4.3967 | +82.34% |
| April, 2026 | $3.9772 | $2.9372 | $6.3372 | +117.33% |
| May, 2026 | $3.5575 | $3.3772 | $4.0372 | +94.40% |
| June, 2026 | $3.4377 | $3.1777 | $3.8176 | +87.85% |
| July, 2026 | $3.7585 | $3.3398 | $4.0378 | +105.38% |
| August, 2026 | $3.8184 | $3.4333 | $4.0284 | +108.65% |
| September, 2026 | $4.6787 | $3.5086 | $6.9187 | +155.67% |
| October, 2026 | $4.819 | $3.5688 | $5.429 | +163.33% |
| November, 2026 | $4.7193 | $4.3591 | $5.8792 | +157.88% |
| December, 2026 | $4.1696 | $4.0496 | $4.7893 | +127.85% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for X T L Biopharmaceuticals Ltd Adr (XTLB) is $3.1961, with a high forecast of $4.8097 and a low forecast of $1.5825. This indicates an +74.65% increase from the last price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.1999 | $3.8298 | $4.8097 | +129.50% |
| February, 2027 | $3.4302 | $3.1901 | $4.19 | +87.44% |
| March, 2027 | $3.0005 | $2.7909 | $3.6802 | +63.96% |
| April, 2027 | $2.6708 | $2.4808 | $3.2307 | +45.95% |
| May, 2027 | $2.611 | $2.5012 | $2.8323 | +42.68% |
| June, 2027 | $2.4314 | $2.2814 | $2.7511 | +32.86% |
| July, 2027 | $2.4393 | $2.2915 | $2.8815 | +33.30% |
| August, 2027 | $2.332 | $2.072 | $2.7018 | +27.43% |
| September, 2027 | $1.9523 | $1.712 | $2.252 | +6.68% |
| October, 2027 | $1.7516 | $1.5825 | $2.0124 | -4.28% |
| November, 2027 | $1.9229 | $1.6827 | $2.0429 | +5.08% |
| December, 2027 | $1.8432 | $1.723 | $2.4531 | +0.72% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2028
In 2028, X T L Biopharmaceuticals Ltd Adr (XTLB) is projected to reach an average price of $1.0334, with a high projection of $1.8333 and a low estimate of $0.2335. This indicates an -43.53% fall from the last price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2335 | $0.2335 | $1.8333 | -87.24% |
| February, 2028 | $1.4388 | $1.084 | $1.7036 | -21.38% |
| March, 2028 | $1.6241 | $1.3568 | $1.6941 | -11.25% |
| April, 2028 | $1.4598 | $1.4381 | $1.7342 | -20.23% |
| May, 2028 | $1.6248 | $1.2746 | $1.6248 | -11.22% |
| June, 2028 | $1.405 | $1.395 | $1.6349 | -23.22% |
| July, 2028 | $1.58 | $1.4251 | $1.6853 | -13.66% |
| August, 2028 | $1.4457 | $1.4056 | $1.6455 | -21.00% |
| September, 2028 | $1.4559 | $1.3657 | $1.7759 | -20.44% |
| October, 2028 | $1.5562 | $1.2961 | $1.6262 | -14.96% |
| November, 2028 | $1.5366 | $1.3666 | $1.5866 | -16.03% |
| December, 2028 | $1.2569 | $1.157 | $1.5766 | -31.32% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2029
The 2029 price forecast for X T L Biopharmaceuticals Ltd Adr Stock (XTLB) is $3.1083 on average, with a high prediction of $5.2295 and a low estimate of $0.987. This represents an +69.85% increase from the previous price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.0274 | $0.987 | $1.2769 | -43.86% |
| February, 2029 | $1.2111 | $0.9973 | $1.3274 | -33.82% |
| March, 2029 | $1.1354 | $1.0578 | $1.2877 | -37.96% |
| April, 2029 | $1.0581 | $1.0128 | $1.2528 | -42.18% |
| May, 2029 | $1.2484 | $0.9881 | $1.2684 | -31.78% |
| June, 2029 | $1.1787 | $1.1539 | $1.3686 | -35.59% |
| July, 2029 | $1.1099 | $0.9987 | $1.4089 | -39.35% |
| August, 2029 | $1.1093 | $1.0392 | $1.1612 | -39.38% |
| September, 2029 | $1.1396 | $1.0076 | $1.1893 | -37.73% |
| October, 2029 | $3.4999 | $1.0846 | $5.2295 | +91.25% |
| November, 2029 | $2.8302 | $2.5901 | $3.475 | +54.66% |
| December, 2029 | $2.5954 | $2.5903 | $2.9201 | +41.82% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2030
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) is expected to reach an average price of $1.9211 in 2030, with a high forecast of $2.7706 and a low forecast of $1.0715. This signifies an +4.98% surge from the last price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.441 | $2.3404 | $2.7706 | +33.39% |
| February, 2030 | $2.3915 | $2.2213 | $2.6015 | +30.68% |
| March, 2030 | $2.3421 | $2.152 | $2.482 | +27.98% |
| April, 2030 | $2.3355 | $2.0726 | $2.4095 | +27.63% |
| May, 2030 | $1.7573 | $1.7573 | $2.2731 | -3.97% |
| June, 2030 | $1.7559 | $1.6939 | $2.0336 | -4.05% |
| July, 2030 | $1.7078 | $1.644 | $1.8342 | -6.68% |
| August, 2030 | $1.7252 | $1.6677 | $2.0649 | -5.73% |
| September, 2030 | $1.9457 | $1.6453 | $2.2306 | +6.32% |
| October, 2030 | $1.2864 | $1.2772 | $1.9961 | -29.70% |
| November, 2030 | $1.4428 | $1.0715 | $1.6468 | -21.16% |
| December, 2030 | $1.6475 | $1.3622 | $1.8075 | -9.97% |
0.93%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):